您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (8): 91-97.doi: 10.6040/j.issn.1671-7554.0.2022.0417

• 临床医学 • 上一篇    下一篇

马尔尼菲篮状菌感染继发噬血细胞综合征1例文献报道

江子晴1,曾彦平1,2,纪晓栋2,左俊岭2   

  1. 1.广州中医药大学第一临床医学院, 广东 广州 510405;2.广州中医药大学第一附属医院急诊科, 广东 广州 510405
  • 发布日期:2022-07-27
  • 通讯作者: 曾彦平. E-mail:zengyanping5036@gzucm.edu.cn
  • 基金资助:
    广东省医学科学技术研究基金(B2021345)

A case report of hemophagocytic syndrome secondary to talaromyces marneffei infection

JIANG Ziqing1, ZENG Yanping1,2, JI Xiaodong2, ZUO Junling2   

  1. 1. The First Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China;
    2. Emergency Department, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, Guangdong, China
  • Published:2022-07-27

PDF (PC)

97

摘要： 目的 对1例临床确诊马尔尼菲篮状菌(TM)感染继发噬血细胞综合征(HPS)患者的诊疗思路进行分析,以期提高临床医生对该病的认识。 方法 收集我院1例TM感染继发HPS患者的临床及实验室资料进行分析,并复习相关文献,对疾病诊疗思路进行总结。 结果 患者,男,53岁,无恶性肿瘤及免疫缺陷病史,出现持续性发热、咳嗽咯痰、皮疹、黄疸、肝脾大、肝功能损害、血红蛋白及血小板下降,炎症指标、甘油三酯、铁蛋白升高,痰真菌培养、外周血宏基因新一代测序找到TM,骨髓涂片找到噬血细胞,诊断为TM感染继发HPS,予伏立康唑抗真菌,人免疫球蛋白冲击联合糖皮质激素治疗。 结论 TM感染临床表现无特异性,诊断困难,同时继发HPS者病情危重,治疗难度大,需根据患者情况酌情调整治疗方案。

关键词: 马尔尼菲篮状菌, 噬血细胞综合征, 诊疗思路

Abstract: Objective To analyze the diagnosis and treatment of a patient with hemophagocytic syndrome(HPS)secondary to talaromyces marneffei(TM)infection, in order to improve clinicians understanding of the disease. Methods Clinical and laboratory data of a patient with TM infection secondary to HPS treated in our hospital were collected and analyzed, and relevant literature was reviewed. Results The patient, a 53-year-old man, with no history of malignant tumor or immune deficiency, presented with persistent fever, cough, expectoration, rashes, jaundice, hepatomegaly, splenomegaly, liver function impairment, decrease of hemoglobin and platelets, and increase of inflammation indicators, triglycerides and ferritin. TM was detected with sputum culture and metagenomic next-generation sequencing of peripheral blood. Macrophages were observed with bone marrow smear. After HPS secondary to TM infection was confirmed, the patient was treated with voriconazole and human immunoglobulin combined with glucocorticoid. Conclusion The clinical manifestations of TM infection are non-specific and the disease is difficult to diagnose. HPS secondary to TM infection increases the difficulty of treatment. Treatment should be tailored according to the condition of patients.

Key words: Talaromyces marneffei, Hemophagocytic syndrome, Diagnosis and treatment

中图分类号: 

  • R453
[1] 朱蕾, 魏沙沙, 张云桂, 等. 艾滋病合并马尔尼菲篮状菌病临床及药敏研究[J]. 皮肤病与性病, 2019, 41(2): 166-169. ZHU Lei, WEI Shasha, ZHANG Yungui, et al. Clinical and susceptibility study of AIDS complicated with Talaromycosis [J]. Journal of Dermatology and Venereology, 2019, 41(2): 166-169.
[2] He LY, Mei X, Lu S, et al. Talaromyces marneffei infection in non-HIV-infected patients in mainland China [J]. Mycoses, 2021, 64(10): 1170-1176.
[3] Li YY, Lin ZY, Shi X, et al. Retrospective analysis of 15 cases of Penicillium marneffei infection in HIV-positive and HIV-negative patients [J]. Microb Pathog, 2017, 105: 321-325. doi: 10.1016/j.micpath.2017.01.026.
[4] Wang PL, Chen YF, Xu H, et al. Acute disseminated Talaromyces marneffei in an immunocompetent patient [J]. Mycopathologia, 2017, 182(7/8): 751-754.
[5] Zhang ZX, Tao FX, Li YN, et al. Disseminated Penicillium marneffei infection recurrence in a non-acquired immune deficiency syndrome patient: a case report [J]. Mol Clin Oncol, 2016, 5(6): 829-831.
[6] Vanittanakom N, Cooper CR Jr, Fisher MC, et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects [J]. Clin Microbiol Rev, 2006, 19(1): 95-110.
[7] Qiu Y, Liao HF, Zhang JQ, et al. Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study [J]. BMC Infect Dis, 2015, 15: 525. doi: 10.1186/s12879-015-1243-y.
[8] Cao CW, Xi LY, Chaturvedi V. Talaromycosis(penicilliosis)due to Talaromyces(Penicillium)marneffei: insights into the clinical trends of a major fungal disease 60 Years after the discovery of the pathogen [J]. Mycopathologia, 2019, 184(6): 709-720.
[9] Vanittanakom N, Cooper CR, Jr Fisher MC, et al. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects [J]. Clin Microbiol Rev, 2006, 19(1): 95-110.
[10] Ning CY, Lai JZ, Wei WD, et al. Accuracy of rapid diagnosis of Talaromyces marneffei: a systematic review and meta-analysis [J]. PLoS One, 2018, 13(4): e0195569.
[11] Pruksaphon K, Intaramat A, Ratanabanangkoon K, et al. Diagnostic laboratory immunology for talaromycosis(penicilliosis): review from the bench-top techniques to the point-of-care testing[J]. Diagn Microbiol Infect Dis, 2020, 96(3):114959.
[12] Li HN, Gao H, Meng H, et al. Detection of pulmonary infectious pathogens from lung biopsy tissues by metagenomic next-generation sequencing [J]. Front Cell Infect Microbiol, 2018, 8: 205. doi: 10.3389/fcimb.2018.00205.
[13] 李学青, 王丽娜, 张俐, 等. 肺泡灌洗液二代基因测序对儿童重症肺炎病原学诊断应用观察[J]. 中国实用儿科杂志, 2019, 34(6): 513-516. LI Xueqing, WANG Lina, ZHANG Li, et al. Application of alveolar lavage fluid mNGS in the etiological diagnosis of children with severe pneumonia [J]. Chinese Journal of Practical Pediatrics, 2019, 34(6): 513-516.
[14] 张淋, 洪城, 孟新科, 等. 宏基因组学第二代测序技术对比传统实验室微生物培养在脓毒症病原学诊断中的优势[J]. 中国急救医学, 2022, 42(2): 114-120. ZHANG Lin, HONG Cheng, MENG Xinke, et al. The advantages of metagenomic next - generation sequencing compared with traditional laboratory microbial culture in the pathogen diagnosis of sepsis [J]. Chinese Journal of Critical Care Medicine, 2022, 42(2): 114-120.
[15] Larsson M, Nguyen LHT, Wertheim HF, et al. Clinical characteristics and outcome of penicillium marneffei infection among HIV-infected patients in northern Vietnam [J]. AIDS Res Ther, 2012, 9(1): 24.
[16] Ouyang YY, Cai SQ, Liang H, et al. Administration of voriconazole in disseminated Talaromyces(Penicillium)marneffei infection: a retrospective study [J]. Mycopathologia, 2017, 182(5/6): 569-575.
[17] “十三五”国家科技重大专项艾滋病机会性感染课题组.艾滋病合并马尔尼菲篮状菌病临床诊疗的专家共识[J]. 西南大学学报(自然科学版), 2020, 42(7): 61-75. AIDS-Associated Opportunistic Infections Research Group of the National Science and Technology Major Project of China During the 13th Five Year Plan Period. Expert consensus on the diagnosis and treatment of talaromycosis in AIDS patients in China [J]. Journal of Southwest University(Natural Science Edition), 2020, 42(7): 61-75.
[18] Campo M, Berliner N. Hemophagocytic lymphohistiocytosis in adults [J]. Hematol Oncol Clin North Am, 2015, 29(5): 915-925.
[19] Chellapandian D. Hemophagocytic lymphohistiocytosis: lessons learned from the dark side [J]. Immunol Allergy clin North Am, 2020, 40(3): 485-497.
[20] Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment[J]. J pediatr, 2013, 163(5):1253-1259.
[21] Athale J. Challenges in identifying hemophagocytic lymphohistiocytosis in the ICU [J]. Crit Care Med, 2020, 48(4): 599-600.
[22] 周海丰. 慢性乙型肝炎、乙肝肝硬化及原发性肝癌患者血清CEA、AFP、CA125和CA199水平检测分析[J]. 临床合理用药杂志, 2020, 13(23): 124-126.
[23] 蔡锋, 朱运海, 赵杰, 等. 急性梗阻性化脓性胆管炎与糖类抗原199和血小板计数变化的关系[J]. 中华实验外科杂志, 2021, 38(8): 1563-1566. CAI Feng, ZHU Yunhai, ZHAO Jie, et al. Correlation between carbohydrate antigen 199, platelet count and acute obstructive suppurative cholangitis [J]. Chinese Journal of Experimental Surgery, 2021, 38(8): 1563-1566.
[24] Robert M, Jarlier M, Gourgou S, et al. Retrospective analysis of CA19-9 decrease in patients with metastatic pancreatic carcinoma treated with FOLFIRINOX or gemcitabine in a randomized phase III study(ACCORD11/PRODIGE4)[J]. Oncology, 2017, 93(6): 367-376.
[25] 唐伟萍, 钟楠, 陈志未, 等. 噬血细胞综合征患者肝功能损害的临床特点分析[J]. 中国实验血液学杂志, 2019, 27(4): 1297-1304. TANG Weiping, ZHONG Nan, CHEN Zhiwei, et al. Clinical characteristics of liver dysfunction in patients with hemophagocytic syndrome [J]. Journal of Experimental Hematology, 2019, 27(4):1297-1304.
[26] Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis [J]. Am J Hematol, 2015, 90(3): 220-224.
[27] Delavigne K, Bérard E, Bertoli S, et al. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy [J]. Haematologica, 2014, 99(3): 474-480.
[28] Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide [J]. Br J Haematol, 2015, 168(1): 63-68.
[29] 王新凯, 王晶石, 王旖旎, 等. 噬血细胞综合征患者红细胞寿命的检测及其对患者贫血的影响分析[J]. 中国实验血液学杂志, 2020, 28(2): 652-656. WANG Xinkai, WANG Jingshi, WANG Yini, et al. Detection of erythrocyte life and analysis of its effect on the anemia in patients with hemophagocytic syndrome [J]. Journal of Experimental Hematology, 2020, 28(2): 652-656.
[30] 王澎, 翟丽慧, 范洪伟, 等. 9例非HIV感染患者马尔尼菲蓝状菌播散感染的回顾性分析报告[J]. 中国真菌学杂志, 2016, 11(5): 261-264. WANG Peng, ZHAI Lihui, FAN Hongwei, et al. Retrospective analysis of the clinical and laboratory features of 9 disseminated Talaromyces marneffei cases in non-HIV patients [J]. Chinese Journal of Mycology,2016, 11(5): 261-264.
[31] Jiang J, Meng S, Huang S, et al. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China:a retrospective cohort study [J]. Clin Microbiol Infect, 2019, 25(2): 233-241.
[32] Knaak C, Schuster FS, Nyvlt P, et al. Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a systematic review with pooled analysis[J]. Crit Care Med, 2020, 48(11): e1137-e1146.
[33] Pan M, Qiu Y, Zeng W, et al. Talaromycosis-associated secondary hemophagocytic lymphohistiocytosis in nine human immunodeficiency virus-negative patients: a multicenter retrospective study [J]. Infect Drug Resist, 2019, 12: 3807-3816. doi: 10.2147/IDR.S232713.
[1] 孙晨曦, 王永静, 李爱, 宋宁霞, 陈慧娴, 冯晓丽, 邓玉鹏, 王涓冬, 郑成云. 1例罕见成年XLP-1病例报道[J]. 山东大学学报 (医学版), 2022, 60(3): 117-120.
[2] 涂玉凤,赵馥. 噬血细胞综合征伴急性肾损伤1例[J]. 山东大学学报 (医学版), 2019, 57(6): 117-121.
[3] 李凡,邵建华,赵红玉,窦春慧,吕亚辉,李大启. 32例成人继发性噬血细胞综合征临床特点和预后分析[J]. 山东大学学报 (医学版), 2019, 57(12): 62-67.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32 -37 .
[2] 索东阳,申飞,郭皓,刘力畅,杨惠敏,杨向东. Tim-3在药物性急性肾损伤动物模型中的表达及作用机制[J]. 山东大学学报 (医学版), 2020, 1(7): 1 -6 .
[3] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7 -14 .
[4] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24 -31 .
[5] 龙婷婷,谢明,周璐,朱俊德. Noggin蛋白对小鼠脑缺血再灌注损伤后学习和记忆能力与齿状回结构的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 15 -23 .
[6] 李宁,李娟,谢艳,李培龙,王允山,杜鲁涛,王传新. 长链非编码RNA AL109955.1在80例结直肠癌组织中的表达及对细胞增殖与迁移侵袭的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 38 -46 .
[7] 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60 -66 .
[8] 徐玉香,刘煜东,张蓬,段瑞生. 101例脑小血管病患者脑微出血危险因素的回顾性分析[J]. 山东大学学报 (医学版), 2020, 1(7): 67 -71 .
[9] 肖娟,肖强,丛伟,李婷,丁守銮,张媛,邵纯纯,吴梅,刘佳宁,贾红英. 两种甲状腺超声数据报告系统诊断效能的比较[J]. 山东大学学报 (医学版), 2020, 1(7): 53 -59 .
[10] 郭志华,赵大庆,邢园,王薇,梁乐平,杨静,赵倩倩. Ⅰ期端端吻合术治疗重度颈段气管狭窄临床分析[J]. 山东大学学报 (医学版), 2020, 1(7): 72 -76 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发